Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Oregon?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. An Oregon resident can obtain FDA approved peptides such as semaglutide and tirzepatide from an Oregon-licensed prescriber. ORS 677.494 lets physicians and physician associates use synchronous or asynchronous telemedicine to establish the provider-patient relationship and prescribe, and Oregon Medical Board policy says treatment based solely on an online questionnaire without individualized review and assessment is not an acceptable standard of care. A resident can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy registered with the Oregon Board of Pharmacy as an in-state or out-of-state drug outlet. The Board of Pharmacy regulates compounding through OAR chapter 855, division 183 (adopted June 17, 2026), which incorporates USP standards and follows the FDA 503A bulks framework rather than a separate Oregon list.

Regulatory: Telehealth allowedRegulatory: Async allowedRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous allowed; a questionnaire alone is not enough
Compounded GLP-1
Limited

Can a Oregon resident get peptides by telehealth?

ORS 677.494 defines telemedicine for physicians and physician associates to include synchronous technologies used in real time and asynchronous technologies used in other than real time. It says a licensee may use telemedicine to practice medicine for a patient located in Oregon, including establishing the provider-patient relationship, diagnosing or treating a condition, and prescribing drugs, and that the practice occurs where the patient is located. The Oregon Medical Board's Statement of Philosophy on Telemedicine holds telemedicine to the same standard of care as in-person practice and says treatment based solely on an online questionnaire without individualized review and assessment is not an acceptable standard of care. Peptides in this database are not controlled substances. This record classifies asynchronous prescribing as allowed because the statute expressly includes asynchronous technologies in telemedicine and expressly permits establishing the relationship and prescribing through it, while Board policy bars questionnaire-only treatment. [3] [4]

How does the Oregon pharmacy board treat compounding?

Compounding regulator for Oregon
BoardOregon Board of Pharmacy
Eligible substancesFollows the federal 503A framework

The Oregon Board of Pharmacy registers drug outlets under ORS chapter 689: ORS 689.005 defines a drug outlet to include any establishment with facilities located within or out of Oregon that dispenses or delivers drugs in Oregon, and ORS 689.305 requires all drug outlets to register annually. OAR 855-041-1060 requires every non-resident pharmacy that provides drugs or services to a person in Oregon to register with the Board, to be registered in its home state, and to designate an Oregon-licensed pharmacist-in-charge. Compounding is governed by OAR chapter 855, division 183 (Drug Compounding), adopted effective June 17, 2026 in place of the former division 45. OAR 855-183-0001 applies the division to sterile and non-sterile compounding and requires any entity inside or outside Oregon that compounds for dispensing or delivery in Oregon to register as a drug outlet; OAR 855-183-0015 requires compliance with USP chapters 795, 797, and 800 and, from November 1, 2027, requires non-resident outlets that compound to show home-state inspection against current USP standards or an approved accreditation. Oregon has not created a state bulks list; eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [6] [7] [8] [10]

Can you get compounded GLP-1s in Oregon?

Regulatory: Compounded GLP-1 limited

Telehealth GLP-1 patients should confirm the dispensing pharmacy appears in the Board of Pharmacy license lookup. [1] [13]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Oregon?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Oregon

What you'll actually find in Oregon, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [18] [19] [20]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [21]

What Oregon has done

PeptideAgent has not found a board or legislative action on peptides in Oregon.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [23] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [24] [25] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Oregon. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. State law says an online questionnaire alone is not enough. [3] [4] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Oregon Board of Pharmacy; its license search: FDA BeSafeRx: state board of pharmacy license lookups. [22]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [21]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [11] [26] [27]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [22] [28] [29]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [20] [29] [30]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [21] [31] [32] [33] [34] [35]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [21]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [22]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [20]
  • Pharmacy: Is this made for me on a prescription written in my name? [30]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [20] [29]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [20]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Oregon?

ORS chapter 689 restricts dispensing of prescription drugs to registered pharmacies and licensed practitioners, and a seller of "research use only" injectable peptides to Oregon consumers is not a registered drug outlet. Oregon's Unlawful Trade Practices Act, ORS 646.608(1)(e), makes it unlawful in the course of business to represent that goods have characteristics, uses, or benefits that they do not have. [6] [9] [14]

Peptide-specific notes for Oregon

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Can I get a GLP-1 prescription in Oregon through telemedicine?

Yes. ORS 677.494 lets a physician or physician associate use telemedicine to establish the provider-patient relationship and prescribe drugs for a patient located in Oregon. The statute's definition of telemedicine covers both real-time and asynchronous technologies, so that statute does not require a live visit. The Oregon Medical Board's policy statement says treatment based solely on an online questionnaire without individualized review and assessment is not an acceptable standard of care. [3] [4]

Can an out-of-state telehealth doctor treat me in Oregon?

Only if the physician holds a full Oregon license or an Oregon license for the practice of medicine across state lines under OAR 847-025. Oregon is not a member of the Interstate Medical Licensure Compact, so a compact license does not cover Oregon patients. Look the prescriber up in the Oregon Medical Board license search before paying. [2] [5] [15]

How do I check whether a mail-order pharmacy can ship compounded peptides to Oregon?

Search the Oregon Board of Pharmacy license lookup for the pharmacy. Under ORS 689.305 and OAR 855-041-1060 an out-of-state pharmacy must register with the Board as a non-resident pharmacy before shipping to Oregon patients. If the pharmacy is not listed, the shipment is not lawful in Oregon even if the prescriber is compliant. [1] [6] [7]

Can an Oregon pharmacy compound BPC-157 or other unapproved peptides?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). The draft covers only six single peptides (BPC-157, epitalon, KPV, MOTS-c, semax, TB-500); others, such as CJC-1295 and ipamorelin, are not covered. State law still applies: Oregon has not created a state bulks list; eligibility follows the federal 503A framework. [8] [11] [12] [16] [17]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Oregon Board of Pharmacy
  2. [2]Oregon Medical Board (license search and board policies)
  3. [3]ORS 677.494, Telemedicine; where practice occurs (ORS chapter 677)
  4. [4]Oregon Medical Board Statement of Philosophy: Telemedicine (amended April 4, 2024)
  5. [5]Oregon Administrative Rules chapter 847, division 25, Licensure to Practice Medicine Across State Lines (Oregon Medical Board)
  6. [6]ORS chapter 689, Pharmacists; Drug Outlets; Drug Sales
  7. [7]Oregon Administrative Rule 855-041-1060, Non-Resident Pharmacies
  8. [8]Oregon Administrative Rules chapter 855, division 183, Drug Compounding (Oregon Board of Pharmacy, effective June 17, 2026)
  9. [9]ORS 646.608, Additional unlawful business, trade practices (Unlawful Trade Practices Act)
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Oregon?. https://peptideagent.ai/legal/oregon
HTML link
<a href="https://peptideagent.ai/legal/oregon">Are peptides legal in Oregon?</a>, PeptideAgent, updated October 28, 2026.